Submission Details
| 510(k) Number | K172471 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 15, 2017 |
| Decision Date | May 08, 2018 |
| Days to Decision | 266 days |
| Submission Type | Traditional |
| Review Panel | Medical Genetics (MG) |
| Summary | Summary PDF |
K172471 is an FDA 510(k) clearance for the VENTANA CD30 (Ber-H2) RxDx Assay, a Lambda, Antigen, Antiserum, Control (Class II — Special Controls, product code DEH), submitted by Ventana Medical Systems, Inc. (Tucson, US). The FDA issued a Cleared decision on May 8, 2018, 266 days after receiving the submission on August 15, 2017. This device falls under the Medical Genetics review panel. Regulated under 21 CFR 866.5550.
| 510(k) Number | K172471 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 15, 2017 |
| Decision Date | May 08, 2018 |
| Days to Decision | 266 days |
| Submission Type | Traditional |
| Review Panel | Medical Genetics (MG) |
| Summary | Summary PDF |
| Product Code | DEH — Lambda, Antigen, Antiserum, Control |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5550 |